Journal article

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy

Silvia Darb-Esfahani, Carsten Denkert, Albrecht Stenzinger, Christoph Salat, Bruno Sinn, Christian Schem, Volker Endris, Peter Klare, Wolfgang Schmitt, Jens-Uwe Blohmera, Wilko Weichert', Markus Moebs, Hans Teschl, Sherko Kuemmeln, Peter Sinn, Christian Jackisch, Manfred Dietel, Toralf Reimer', Sherene Loi, Michael Untch Show all

Oncotarget | IMPACT JOURNALS LLC | Published : 2016